#everolimus
LightNews LightNews
costplusdrugs.com
💡 We have had HUNDREDS of price drops this year... How about ANOTHER ONE!?

www.costplusdrugs.com/medications/...

➡️ Sign up today at costplusdrugs.com/create-account
Price drop on 0.5mg Everolimus. The new price for 30 tablets is $89.40. Old price was $128.60.
December 12, 2024 at 9:40 PM
lapsyrevoltee.bsky.social
Hormones thyroïdiennes : lévothyroxine
Immunosuppresseurs : évérolimus, tacrolimus, sirolimus
Inhibiteurs de la pompe à protons : oméprazole, ésoméprazole
Antibiotiques : rifampicine, rifabutine
Antifongiques : griséofulvine
Myorelaxants : tizanidine 5/
March 15, 2025 at 12:13 PM
nejm.org
In ER-positive, HER2-negative advanced breast cancer, giredestrant, an ER degrader and full ER antagonist, plus everolimus led to longer progression-free survival than standard endocrine therapy–everolimus; safety was similar. Full phase 3 evERA Breast Cancer trial results: https://nej.md/47ryfbF
A graph from an Original Article published in the New England Journal of Medicine article titled "Giredestrant plus Everolimus in Advanced Breast Cancer." The graph shows progression-free survival among patients with ESR1-mutated tumors. The trial name, evERA Breast Cancer, is in parentheses after the title. The NEJM identity sits at the bottom.
September 30, 2026 at 9:10 PM
jama.com
In children 6-months after heart transplant, everolimus with low-dose tacrolimus was as effective as standard therapy in preventing major complications and showed potential benefits for kidney function and reduced cytomegalovirus infection.

ja.ma/4gyS1WK
JAMA study on children's heart transplants. Conclusion: Everolimus with low-dose tacrolimus appears safe. 211 patients randomized. MATE-3 score: Everolimus 0.9, Mycophenolate 1.3. MATE-6 score: Everolimus 2.0, Mycophenolate 2.4.
September 17, 2025 at 3:30 PM
yourdigitalbrain.bsky.social
Lucas Jemeljanova was diagnosed with DIPG at age six and joined the BIOMEDE trial. After radiation therapy and everolimus, he survived more than six years without visible signs of the tumor on imaging.
August 26, 2026 at 9:00 AM
giorgialodi.bsky.social
Un bambino di 13 anni guarisce da un tumore al cervello

Evviva la scienza 🎉🎉

#cosebelle

www.leggo.it/AMP/schede/t...
Guarisce dal tumore al cervello, Lucas (13 anni) è il primo al mondo a rispondere al farmaco sperimentale Everolimus
Nonostante siano una delle principali cause di morte nel mondo, non tutti i tumori, anche quelli più gravi, sono imbattibili. A testimoniarlo è la straordinaria storia di Lucas...
www.leggo.it
June 16, 2026 at 6:13 AM
hustendoktor.bsky.social
Die Antwort: Es handelt sich tatsächlich um eine fortgeschrittene LAM. Wenn ihr mal die Kombi ,,mittelalte Frau mit Löchern in der Lunge ohne irgendwelche anderen Gründe" seht dran denken :)
Therapie wäre Everolimus od Sirolimus
de.wikipedia.org/wiki/Lymphan...
Lymphangioleiomyomatose – Wikipedia
de.wikipedia.org
March 28, 2025 at 1:45 PM
edgarvlermamd.medsky.network
What other Landmark Trials in ADPKD should be included in this list⁉️ @askrenal.bsky.social
#Nephpearls #NephSky #AskRenal

⏹️ CRISP
⏹️ Everolimus
⏹️ TEMPO 3:4
⏹️ HALT A
⏹️ HALT B
⏹️ REPRISE

👉🏽 landmarknephrology.com/topic/adpkd/
January 11, 2025 at 3:14 AM
oncoalert.bsky.social
Giredestrant plus Everolimus in Advanced Breast Cancer

Could targeting both ER and PI3K–AKT–mTOR pathways help overcome endocrine resistance? 👇
www.nejm.org/doi/full/10....
October 1, 2026 at 9:52 AM
paytonsnewheart.bsky.social
My story with @truthrx.org is live.

It covers “ghost approvals” and mentions @mcuban.bsky.social, @costplusdrugs.com @warrisbokhari.bsky.social from @getclaimable.bsky.social, and Mary Cutter, my donor Christian’s mom.

“Approved” should mean accessible.

puttrx.medium.com/ghost-approv...
Ghost Approvals: The Insurance Practice That’s Putting Patients at Risk
At 11 years old, Payton Herres received a heart transplant that saved her life. Now 26, she relies on a daily immunosuppressant, Everolimus…
puttrx.medium.com
June 26, 2026 at 1:55 PM
vcclibrary.bsky.social
Giredestrant plus Everolimus in Advanced #BreastCancer. www.nejm.org/doi/full/10....
Giredestrant plus Everolimus in Advanced Breast Cancer | NEJM
Giredestrant and everolimus target the estrogen receptor (ER) pathway and the phosphatidylinositol 3-kinase (PI3K)–protein kinase B (AKT)–mammalian target of rapamycin (mTOR) pathway, respectively,...
www.nejm.org
October 1, 2026 at 11:08 AM
ascocancer.bsky.social
New research just presented at #GI25: STARTER-NET trial shows everolimus + lanreotide more than doubles PFS vs everolimus monotherapy among pts w/ aggressive GEP-NETs: brnw.ch/21wQeCg
#ASCODailyNews #GICSM
January 24, 2025 at 9:33 PM
ascocancer.bsky.social
New #NETCancer research from #GI25: Combination of everolimus and lanreotide helps patients with GEP-NETs live longer without cancer growth compared to everolimus alone. Read a plain language summary from us.
ASCO Gastrointestinal Cancers Symposium - Research Summaries for Patients
Visit this page during the meeting to find patient-friendly summaries of highlighted research.
society.asco.org
January 24, 2025 at 9:16 PM
bettinafrank.bsky.social
"EMA-Warnung zu Paxlovid®: Hinweis auf schwerwiegende unerwünschte Wirkungen bei gleichzeitiger Einnahme bestimmter Immunsuppressiva!

Die Fähigkeit des Körpers, Paxlovid® auszuscheiden, wird durch Wechselwirkungen beeinträchtigt."

deutsch.medscape.com/artikelansic...
EMA: Paxlovid® und Immunsuppressiva – eine gefährliche Kombination
Paxlovid® sollte zusammen mit Tacrolimus, Ciclosporin, Everolimus oder Sirolimus nur verabreicht werden, wenn eine engmaschige Überwachung der Blutspiegel möglich ist.
deutsch.medscape.com
February 9, 2024 at 2:01 PM
zachuchnanost.bsky.social
Nikde jsem se to nedočetla, ani v zahraničních lékařských textech ani v příbalových letácích, takže mám vlastní objevnou zkušenost, jaké to je, vysadit imunosupresivní lék everolimus.
🧵
October 2, 2024 at 10:03 AM
hswapnil.medsky.social
low dose Tac + Everolimus is not superior to Tac + MMF in older transplant recipients

in @asnpublications.bsky.social

another LBCT from #KidneyWk published

journals.lww.com/jasn/fulltex...
journals.lww.com
November 7, 2025 at 6:53 PM
jolu.bsky.social
"EMA-Warnung zu #Paxlovid: Hinweis auf schwerwiegende unerwünschte Wirkungen bei gleichzeitiger Einnahme bestimmter Immunsuppressiva." / v. 9.2.24

#CovidIsNotOver #MaskUp #TeamVorsicht #LongCovid
EMA: Paxlovid® und Immunsuppressiva – eine gefährliche Kombination
Paxlovid® sollte zusammen mit Tacrolimus, Ciclosporin, Everolimus oder Sirolimus nur verabreicht werden, wenn eine engmaschige Überwachung der Blutspiegel möglich ist.
deutsch.medscape.com
February 9, 2024 at 12:58 PM
onclive.bsky.social
Everolimus Plus Lanreotide Extends PFS in Advanced GEP-NETs @ascocancer.bsky.social #GI25 #oncology www.onclive.com/view/everoli...
Everolimus Plus Lanreotide Extends PFS in Advanced GEP-NETs
Everolimus plus lanreotide demonstrated an improved PFS compared with everolimus monotherapy in gastroenteropancreatic neuroendocrine tumors.
www.onclive.com
January 21, 2025 at 10:07 PM
shwetalm.bsky.social
Very excited to have this collaborative work on evaluating PK/PD and single-cell responses for Ribociclib+Everolimus in #rGBM published. It was such a great experience working with @kevin-johnson.bsky.social and @roelverhaak.bsky.social. @ivycenter.bsky.social @anchitien.bsky.social
November 8, 2025 at 6:04 PM
theisn.org
𝗜𝗦𝗡 𝗩𝗜𝗗𝗘𝗢 𝗔𝗕𝗦𝗧𝗥𝗔𝗖𝗧 𝗦𝗘𝗥𝗜𝗘𝗦: Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipients www.kidney-internati...

#VideoAbstract by @raphapalma.bsky.social & @acssjr.bsky.social
April 8, 2025 at 12:00 PM
edgarvlermamd.medsky.network
What other Landmark Trials in ADPKD should be included in this list⁉️
#Nephpearls #NephJC #NephSky

⏹️ CRISP pubmed.ncbi.nlm.nih.gov/16707749/
⏹️ Everolimus pubmed.ncbi.nlm.nih.gov/20581392/
⏹️ TEMPO 3:4
pubmed.ncbi.nlm.nih.gov/23121377/
⏹️ HALT A pubmed.ncbi.nlm.nih.gov/25399733/
⏹️ HALT B
⏹️ REPRISE
March 26, 2025 at 1:41 AM
cloves.bsky.social
Sexy everolimus otc drug interactions
October 26, 2025 at 12:25 AM
epilepsiajournal.bsky.social
Our findings suggest that everolimus is a promising precision therapy for NPRL2- and NPRL3-related epilepsy, with the potential to reduce seizure frequency, thereby improving patient quality of life.
doi.org/10.1111/epi....

#epilepsy #Epilepsia #ILAE #everolimus #GATOR1complex #mTORpathway
July 30, 2025 at 5:25 PM
transplantrockstar.bsky.social
Everolimus is ridiculously expensive. January Rx covers my OOP max for the year!

My copay makes apixa 50

Had i still been in denmark when my liver failed, i likely would not have been approved in time (was an emergency here) and i likely would not have been started on apixa & everolimus
April 15, 2026 at 10:36 PM
cp-cellrepmed.bsky.social
Online now: System analysis links SMARCD3 regulons to growth signaling and MEK inhibitor response in everolimus-resistant ER+ breast cancer cells
System analysis links SMARCD3 regulons to growth signaling and MEK inhibitor response in everolimus-resistant ER+ breast cancer cells
Everolimus is approved for treating advanced ER+ breast cancers, yet many patients develop resistance. Medina et al. identify SMARCD3 regulons linked to activation of alternate growth-factor signaling and MEK1/2 inhibitor sensitivity in resistant cells, revealing an effective strategy to overcome everolimus resistance in ER+ breast cancer.
dlvr.it
November 20, 2025 at 8:19 PM